Cleared Traditional

Adaptix™ PEEK Interbody System with Nanotechnology (K241605) - FDA 510(k) Clearance

Also marketed or referenced as:
Capstone Control™ PEEK Spinal System with Nanotechnology

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K241605 · Nanovis, LLC · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2024
Decision
93d
Days
Class 2
Risk

K241605 is an FDA 510(k) clearance for the Adaptix™ PEEK Interbody System with Nanotechnology. Classified as Intervertebral Fusion Device With Bone Graft, Lumbar within the MAX classification (a category for intervertebral fusion devices and spinal implants), Class II - Special Controls.

Submitted by Nanovis, LLC (Columbia City, US). The FDA issued a Cleared decision on September 5, 2024 after a review of 93 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3080 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Nanovis, LLC devices

Submission Details

510(k) Number K241605 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 04, 2024
Decision Date September 05, 2024
Days to Decision 93 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
29d faster than avg
Panel avg: 122d · This submission: 93d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MAX Intervertebral Fusion Device With Bone Graft, Lumbar
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3080
Definition Intended To Stabilize Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Backroads Consulting, Inc.
Karen Warden

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MAX Intervertebral Fusion Device With Bone Graft, Lumbar

All 464
Devices cleared under the same product code (MAX) and FDA review panel - the closest regulatory comparables to K241605.
Iatrical Interbody Lumbar Fusion Systems (Model ALIF, Model TLIF, Model LLIF)
K232996 · Shanghai Iatrical-Ti Technologies CO , Ltd. · Sep 2024
COSINE™ Spacer
K234035 · Globus Medical, Inc. · Sep 2024
IB3D™ PL Spinal System
K241164 · Medicrea International S.A.S. (Medtronic) · Sep 2024
aprevo® Anterior and Lateral Lumbar Interbody Fusion device (ALIF/LLIF)
K241328 · Carlsmed, Inc. · Aug 2024
Solar™ Lumbar Interbody Fusion System
K240326 · Degen Medical, Inc. · Jul 2024
sagAlign Lumbar Cage System (Various PNs)
K241413 · Acuity Surgical Devices, LLC · Jul 2024